This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
The Society of Cannabis Clinicians (SCC) is seeking interns to support the organization in various ways. These internships will provide an opportunity to work with a society of experts and deepen skills and experience in the cannabis field. Learn more.
SCC Members Dr. Michelle Sexton and Dr. Jamie Carroon spotlight the applications of cannabis from the naturopathic physician perspective. In this interview, the two discuss the role of the CB2 receptor on immune function and inflammation and how this can alleviate migraines and other conditions.
Dawn-Marie Steentra, LPN guides us through a day in the life of a Cannabis Nurse. The work requires ongoing compassion, education, and enthusiasm for patient advocacy.
Dr. Kevin M.Takakuwa details the history of the SCC, which is the first and oldest U.S. medical organization promoting the use of medical cannabis.
Expert Opinion on Drug Metabolism & Toxicology, 9 April 2020
—
Introduction: Recent trials using cannabidiol (CBD) have shown that most acute and prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects (SAEs). This review focused on analyzing SAEs of CBD and their possible relation to drug-drug interaction…
Neuropsychopharmacology, 8 April 2020
—
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety. We conducted the first systematic review and meta-analysis of the adverse effects of CBD across all medical indications. Double-blind randomized plac…
Bobby Eisenberg has worked with El Dorado officials to develop regulations that recognize a patient’s right to grow as much cannabis as their doctor authorizes. Now the planning commission in El Dorado Country wants to impose a six-plant limit.
What would we envision as the best cannabis model for international patient access? This question was explored at a collaborative event in Barcelona just before the COVID-19 lockdowns swept over Spain (and the world).
Joe D. Goldstrich, MD, FACC outlines what we know about the antiviral properties of cannabis and whether or not it could be helpful or detrimental for COVID-19.
Frontiers in Pharmacology, 25 March 2020
—
The entourage effect was a proposed explanation for biological observations that endocannabinoid ligand activities can be modified by other lipids released from cells at the same time. An increasing volume of anecdotal reports and interest in the plant have provoked research i…
Sarah Mann, MD separates myth and conjecture from what is known (and unknown) about cannabis and sex.
Cannabis and Cannabinoid Research, 6 March 2020
—
Introduction: Interest in the therapeutic use of cannabidiol (CBD) has reached a fever-pitch in recent months, as CBD-containing products appear everywhere from online retailers to grocery stores and gas stations. The widespread availability of hemp-derived CBD products is con…